Source: Biomedicine and Pharmacotherapy. Unidades: FCFRP, IFSC
Subjects: TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS, CRISTALOGRAFIA
ABNT
PAIXÃO, Drielly A. et al. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex. Biomedicine and Pharmacotherapy, v. 109, n. Ja 2019, p. 157-166, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2018.10.057. Acesso em: 17 ago. 2024.APA
Paixão, D. A., Lopes, C. D., Carneiro, Z. A., Sousa, L. M., Oliveira, L. P., Lopes, N. P., et al. (2019). In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex. Biomedicine and Pharmacotherapy, 109( Ja 2019), 157-166. doi:10.1016/j.biopha.2018.10.057NLM
Paixão DA, Lopes CD, Carneiro ZA, Sousa LM, Oliveira LP, Lopes NP, Pivatto M, Chaves JDS, Almeida MV, Ellena J, Moreira MB, V. G. Netto A, Oliveira RJ, Guilardi S, Albuquerque S de, Guerra W. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex [Internet]. Biomedicine and Pharmacotherapy. 2019 ; 109( Ja 2019): 157-166.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.biopha.2018.10.057Vancouver
Paixão DA, Lopes CD, Carneiro ZA, Sousa LM, Oliveira LP, Lopes NP, Pivatto M, Chaves JDS, Almeida MV, Ellena J, Moreira MB, V. G. Netto A, Oliveira RJ, Guilardi S, Albuquerque S de, Guerra W. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex [Internet]. Biomedicine and Pharmacotherapy. 2019 ; 109( Ja 2019): 157-166.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.biopha.2018.10.057